These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3754596)
41. The effects of intraperitoneal calcitriol on calcium and parathyroid hormone. Delmez JA; Dougan CS; Gearing BK; Rothstein M; Windus DW; Rapp N; Slatopolsky E Kidney Int; 1987 Mar; 31(3):795-9. PubMed ID: 3573540 [TBL] [Abstract][Full Text] [Related]
42. No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure. Ardissino G; Schmitt CP; Bianchi ML; Daccò V; Claris-Appiani A; Mehls O Kidney Int; 2000 Sep; 58(3):981-8. PubMed ID: 10972662 [TBL] [Abstract][Full Text] [Related]
43. Relative hypoparathyroidism and calcitriol up-regulation in hypercalciuric calcium renal stone formers--impact of nutrition. Hess B; Casez JP; Takkinen R; Ackermann D; Jaeger P Am J Nephrol; 1993; 13(1):18-26. PubMed ID: 8322837 [TBL] [Abstract][Full Text] [Related]
44. Increased plasma concentrations of total and free 1,25-(OH)2D3 in calcium stone formers with idiopathic hypercalciuria. Bataille P; Bouillon R; Fournier A; Renaud H; Gueris J; Idrissi A Contrib Nephrol; 1987; 58():137-42. PubMed ID: 3691117 [No Abstract] [Full Text] [Related]
45. Treatment of congenital osteopetrosis with high-dose calcitriol. Key L; Carnes D; Cole S; Holtrop M; Bar-Shavit Z; Shapiro F; Arceci R; Steinberg J; Gundberg C; Kahn A N Engl J Med; 1984 Feb; 310(7):409-15. PubMed ID: 6546410 [TBL] [Abstract][Full Text] [Related]
47. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Bataille P; Achard JM; Fournier A; Boudailliez B; Westeel PF; el Esper N; Bergot C; Jans I; Lalau JD; Petit J Kidney Int; 1991 Jun; 39(6):1193-205. PubMed ID: 1895673 [TBL] [Abstract][Full Text] [Related]
48. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. Van Den Berg CJ; Kumar R; Wilson DM; Heath H; Smith LH J Clin Endocrinol Metab; 1980 Nov; 51(5):998-1001. PubMed ID: 6893460 [TBL] [Abstract][Full Text] [Related]
49. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728 [TBL] [Abstract][Full Text] [Related]
50. Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets. Calvo MS; Kumar R; Heath H J Clin Endocrinol Metab; 1990 May; 70(5):1334-40. PubMed ID: 2335575 [TBL] [Abstract][Full Text] [Related]
51. Effect of treatment with oral calcitriol on calcium metabolism and fasting serum 25(OH)- or 1,25(OH)2-vitamin D level in Japanese postmenopausal women. Tsukamoto Y; Watanabe T; Nakagami T; Morishita K Endocr J; 2003 Dec; 50(6):681-7. PubMed ID: 14709838 [TBL] [Abstract][Full Text] [Related]
52. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis. Banalagay E; Bernardini J; Holley J; Chen T; Piraino B Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943 [TBL] [Abstract][Full Text] [Related]
53. The effects of the menopause on calcitriol and parathyroid hormone: responses to a low dietary calcium stress test. Prince RL; Dick I; Garcia-Webb P; Retallack RW J Clin Endocrinol Metab; 1990 Apr; 70(4):1119-23. PubMed ID: 2318935 [TBL] [Abstract][Full Text] [Related]